Glaukos GKOS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Corneal Health | $21.31M-11.1% | $23.97M+2.9% | $23.29M+13.1% | $20.59M+11.1% | $18.53M-13.2% | |
| Glaucoma | $129.26M+8.5% | $119.15M+8.1% | $110.25M+6.5% | $103.53M+17.5% | $88.14M+4.7% | |
| Revenue by Geography | ||||||
| Non Us | $38.23M+8.8% | $35.12M+9.5% | $32.09M-4.5% | $33.6M+6.4% | $31.59M+5.6% | |
| US | $112.34M+4.0% | $108M+6.5% | $101.45M+12.1% | $90.52M+20.6% | $75.07M-0.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Glaukos break its business down?
- Glaukos (GKOS) reports revenue by product across 2 parts — Corneal Health and Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Glaukos's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Glaukos's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
